Clinical and Personal Predictors of Helmet-CPAP Use and Failure in Patients Firstly Admitted to Regular Medical Wards with COVID-19-Related Acute Respiratory Distress Syndrome (hCPAP-f Study)

Acute Respiratory Distress Syndrome (ARDS) caused by COVID-19 is substantially different from ARDS caused by other diseases and its treatment is dissimilar and challenging. As many studies showed conflicting results regarding the use of Non-invasive ventilation in COVID-19-associated ARDS, no unques...

Full description

Bibliographic Details
Main Authors: Francesco Cei, Ludia Chiarugi, Simona Brancati, Silvia Dolenti, Maria Silvia Montini, Matteo Rosselli, Mario Filippelli, Chiara Ciacci, Irene Sellerio, Marco Maria Gucci, Giulia Vannini, Rinaldo Lavecchia, Loredana Staglianò, Daniele di Stefano, Tiziana Gurrera, Mario Romagnoli, Valentina Francolini, Francesca Dainelli, Grazia Panigada, Giancarlo Landini, Gianluigi Mazzoccoli, Roberto Tarquini
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/1/207
_version_ 1797445583327199232
author Francesco Cei
Ludia Chiarugi
Simona Brancati
Silvia Dolenti
Maria Silvia Montini
Matteo Rosselli
Mario Filippelli
Chiara Ciacci
Irene Sellerio
Marco Maria Gucci
Giulia Vannini
Rinaldo Lavecchia
Loredana Staglianò
Daniele di Stefano
Tiziana Gurrera
Mario Romagnoli
Valentina Francolini
Francesca Dainelli
Grazia Panigada
Giancarlo Landini
Gianluigi Mazzoccoli
Roberto Tarquini
author_facet Francesco Cei
Ludia Chiarugi
Simona Brancati
Silvia Dolenti
Maria Silvia Montini
Matteo Rosselli
Mario Filippelli
Chiara Ciacci
Irene Sellerio
Marco Maria Gucci
Giulia Vannini
Rinaldo Lavecchia
Loredana Staglianò
Daniele di Stefano
Tiziana Gurrera
Mario Romagnoli
Valentina Francolini
Francesca Dainelli
Grazia Panigada
Giancarlo Landini
Gianluigi Mazzoccoli
Roberto Tarquini
author_sort Francesco Cei
collection DOAJ
description Acute Respiratory Distress Syndrome (ARDS) caused by COVID-19 is substantially different from ARDS caused by other diseases and its treatment is dissimilar and challenging. As many studies showed conflicting results regarding the use of Non-invasive ventilation in COVID-19-associated ARDS, no unquestionable indications by operational guidelines were reported. The aim of this study was to estimate the use and success rate of Helmet (h) Continuous Positive Airway Pressure (CPAP) in COVID-19-associated ARDS in medical regular wards patients and describe the predictive risk factors for its use and failure. In our monocentric retrospective observational study, we included patients admitted for COVID-19 in medical regular wards. hCPAP was delivered when supplemental conventional or high-flow nasal oxygen failed to achieve respiratory targets. The primary outcomes were hCPAP use and failure rate (including the need to use Bilevel (BL) PAP or oro-tracheal intubation (OTI) and death during ventilation). The secondary outcome was the rate of in-hospital death and OTI. We computed a score derived from the factors independently associated with hCPAP failure. Out of 701 patients admitted with COVID-19 symptoms, 295 were diagnosed with ARDS caused by COVID-19 and treated with hCPAP. Factors associated with the need for hCPAP use were the PaO<sub>2</sub>/FiO<sub>2</sub> ratio < 270, IL-6 serum levels over 46 pg/mL, AST > 33 U/L, and LDH > 570 U/L; age > 78 years and neuropsychiatric conditions were associated with lower use of hCPAP. Failure of hCPAP occurred in 125 patients and was associated with male sex, polypharmacotherapy (at least three medications), platelet count < 180 × 10<sup>9</sup>/L, and PaO<sub>2</sub>/FiO<sub>2</sub> ratio < 240. The computed hCPAP-f Score, ranging from 0 to 11.5 points, had an AUC of 0.74 in predicting hCPAP failure (significantly superior to Call Score), and 0.73 for the secondary outcome (non-inferior to IL-6 serum levels). In conclusion, hCPAP was widely used in patients with COVID-19 symptoms admitted to medical regular wards and developing ARDS, with a low OTI rate. A score computed combining male sex, multi-pharmacotherapy, low platelet count, and low PaO<sub>2</sub>/FiO<sub>2</sub> was able to predict hCPAP failure in hospitalized patients with ARDS caused by COVID-19.
first_indexed 2024-03-09T13:27:57Z
format Article
id doaj.art-1fb8c2fef55f425a87fca91034297b0b
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T13:27:57Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-1fb8c2fef55f425a87fca91034297b0b2023-11-30T21:21:02ZengMDPI AGBiomedicines2227-90592023-01-0111120710.3390/biomedicines11010207Clinical and Personal Predictors of Helmet-CPAP Use and Failure in Patients Firstly Admitted to Regular Medical Wards with COVID-19-Related Acute Respiratory Distress Syndrome (hCPAP-f Study)Francesco Cei0Ludia Chiarugi1Simona Brancati2Silvia Dolenti3Maria Silvia Montini4Matteo Rosselli5Mario Filippelli6Chiara Ciacci7Irene Sellerio8Marco Maria Gucci9Giulia Vannini10Rinaldo Lavecchia11Loredana Staglianò12Daniele di Stefano13Tiziana Gurrera14Mario Romagnoli15Valentina Francolini16Francesca Dainelli17Grazia Panigada18Giancarlo Landini19Gianluigi Mazzoccoli20Roberto Tarquini21Division of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine II, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine II, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine II, San Giuseppe Hospital, 50053 Empoli, ItalyDivision of Internal Medicine, SS Cosma and Damiano Hospital, 51017 Pescia, ItalyDivision of Internal Medicine, Santa Maria Nuova Hospital, 50100 Firenze, ItalyDivision of Internal Medicine, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, ItalyDivision of Internal Medicine I, San Giuseppe Hospital, 50053 Empoli, ItalyAcute Respiratory Distress Syndrome (ARDS) caused by COVID-19 is substantially different from ARDS caused by other diseases and its treatment is dissimilar and challenging. As many studies showed conflicting results regarding the use of Non-invasive ventilation in COVID-19-associated ARDS, no unquestionable indications by operational guidelines were reported. The aim of this study was to estimate the use and success rate of Helmet (h) Continuous Positive Airway Pressure (CPAP) in COVID-19-associated ARDS in medical regular wards patients and describe the predictive risk factors for its use and failure. In our monocentric retrospective observational study, we included patients admitted for COVID-19 in medical regular wards. hCPAP was delivered when supplemental conventional or high-flow nasal oxygen failed to achieve respiratory targets. The primary outcomes were hCPAP use and failure rate (including the need to use Bilevel (BL) PAP or oro-tracheal intubation (OTI) and death during ventilation). The secondary outcome was the rate of in-hospital death and OTI. We computed a score derived from the factors independently associated with hCPAP failure. Out of 701 patients admitted with COVID-19 symptoms, 295 were diagnosed with ARDS caused by COVID-19 and treated with hCPAP. Factors associated with the need for hCPAP use were the PaO<sub>2</sub>/FiO<sub>2</sub> ratio < 270, IL-6 serum levels over 46 pg/mL, AST > 33 U/L, and LDH > 570 U/L; age > 78 years and neuropsychiatric conditions were associated with lower use of hCPAP. Failure of hCPAP occurred in 125 patients and was associated with male sex, polypharmacotherapy (at least three medications), platelet count < 180 × 10<sup>9</sup>/L, and PaO<sub>2</sub>/FiO<sub>2</sub> ratio < 240. The computed hCPAP-f Score, ranging from 0 to 11.5 points, had an AUC of 0.74 in predicting hCPAP failure (significantly superior to Call Score), and 0.73 for the secondary outcome (non-inferior to IL-6 serum levels). In conclusion, hCPAP was widely used in patients with COVID-19 symptoms admitted to medical regular wards and developing ARDS, with a low OTI rate. A score computed combining male sex, multi-pharmacotherapy, low platelet count, and low PaO<sub>2</sub>/FiO<sub>2</sub> was able to predict hCPAP failure in hospitalized patients with ARDS caused by COVID-19.https://www.mdpi.com/2227-9059/11/1/207hCPAPnon-invasive ventilationCOVID-19SARS-CoV-2ARDSprognosis
spellingShingle Francesco Cei
Ludia Chiarugi
Simona Brancati
Silvia Dolenti
Maria Silvia Montini
Matteo Rosselli
Mario Filippelli
Chiara Ciacci
Irene Sellerio
Marco Maria Gucci
Giulia Vannini
Rinaldo Lavecchia
Loredana Staglianò
Daniele di Stefano
Tiziana Gurrera
Mario Romagnoli
Valentina Francolini
Francesca Dainelli
Grazia Panigada
Giancarlo Landini
Gianluigi Mazzoccoli
Roberto Tarquini
Clinical and Personal Predictors of Helmet-CPAP Use and Failure in Patients Firstly Admitted to Regular Medical Wards with COVID-19-Related Acute Respiratory Distress Syndrome (hCPAP-f Study)
Biomedicines
hCPAP
non-invasive ventilation
COVID-19
SARS-CoV-2
ARDS
prognosis
title Clinical and Personal Predictors of Helmet-CPAP Use and Failure in Patients Firstly Admitted to Regular Medical Wards with COVID-19-Related Acute Respiratory Distress Syndrome (hCPAP-f Study)
title_full Clinical and Personal Predictors of Helmet-CPAP Use and Failure in Patients Firstly Admitted to Regular Medical Wards with COVID-19-Related Acute Respiratory Distress Syndrome (hCPAP-f Study)
title_fullStr Clinical and Personal Predictors of Helmet-CPAP Use and Failure in Patients Firstly Admitted to Regular Medical Wards with COVID-19-Related Acute Respiratory Distress Syndrome (hCPAP-f Study)
title_full_unstemmed Clinical and Personal Predictors of Helmet-CPAP Use and Failure in Patients Firstly Admitted to Regular Medical Wards with COVID-19-Related Acute Respiratory Distress Syndrome (hCPAP-f Study)
title_short Clinical and Personal Predictors of Helmet-CPAP Use and Failure in Patients Firstly Admitted to Regular Medical Wards with COVID-19-Related Acute Respiratory Distress Syndrome (hCPAP-f Study)
title_sort clinical and personal predictors of helmet cpap use and failure in patients firstly admitted to regular medical wards with covid 19 related acute respiratory distress syndrome hcpap f study
topic hCPAP
non-invasive ventilation
COVID-19
SARS-CoV-2
ARDS
prognosis
url https://www.mdpi.com/2227-9059/11/1/207
work_keys_str_mv AT francescocei clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT ludiachiarugi clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT simonabrancati clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT silviadolenti clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT mariasilviamontini clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT matteorosselli clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT mariofilippelli clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT chiaraciacci clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT irenesellerio clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT marcomariagucci clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT giuliavannini clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT rinaldolavecchia clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT loredanastagliano clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT danieledistefano clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT tizianagurrera clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT marioromagnoli clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT valentinafrancolini clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT francescadainelli clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT graziapanigada clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT giancarlolandini clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT gianluigimazzoccoli clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy
AT robertotarquini clinicalandpersonalpredictorsofhelmetcpapuseandfailureinpatientsfirstlyadmittedtoregularmedicalwardswithcovid19relatedacuterespiratorydistresssyndromehcpapfstudy